0 citations
Insight into the application of nicotinamide mononucleotide (NMN) to age-related disorders
2023Vol. 2(1), pp. 9–13
Citations Over Time
Abstract
Numerous animal studies have shown that the decrease in the tissue Nicotinamide Adenine Dinucleotide (NAD+) levels during aging are closely related to age-related physiological decline and that the administration of NAD+ precursors restore NAD+ levels and promotes health and prolongs lifespan. Therefore, in order to demonstrate whether NAD+ supplementation by NAD+ precursors mitigate age-related physiological dysfunction including muscle weakness in older men. We conducted a placebo-controlled, randomized, double-blind, parallel-group study in which Nicotinamide mononucleotide (NMN) was administered to healthy older men for 12 weeks. In this commentary, we overview reported human NAD+-related clinical trials including our NMN study.
Related Papers
- → Nampt: linking NAD biology, metabolism and cancer(2008)397 cited
- → The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals(2007)308 cited
- → Nampt and Its Potential Role in Inflammation and Type 2 Diabetes(2011)39 cited
- → Evidence for a physiologically active nicotinamide phosphoribosyl transferase in cultured human fibroblasts(1982)19 cited
- → Nicotinamide Mononucleotide Determination of its Enzymatic Formation in vitro and its Physiological Rôle for the Biosynthesis of Nicotinamide‐Adenine Dinucleotide in Mice(1971)15 cited